Company & Sponsor Intelligence
University of Roma La Sapienza
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed0
Countries1
Therapeutic footprint
alzheimersdepressionocd
Indexed studies
NCT04560101Motor and Non-motor Symptoms in Cervical Dystonia
depression · ItalyUNKNOWN
depression · ItalyUNKNOWN
NCT03784183Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients With Alzheimer's Disease and Mild Cognitive Impairment
alzheimers · ItalyNA
alzheimers · ItalyNA
NCT05015595Memantine for Refractory OCD Patients
ocd · PHASE3
ocd · PHASE3
Intelligence layer updated: 2026-11-03 06:12:30.767591+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →